NEW YORK, Jan. 07, 2025 (GLOBE NEWSWIRE) — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Singular Genomics Systems, Inc. (NASDAQ: OMIC)’s sale to an affiliate of Deerfield Management Company, L.P. for $20.00 per share. If you are a Singular Genomics shareholder, click here to learn more about your rights and options.
Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS)’s sale to Immedica Pharma AB for $0.55 per share. If you are a Marinus shareholder, click here to learn more about your rights and options.
Vacasa, Inc. (NASDAQ: VCSA)’s sale to Casago for $5.02 per share. If you are a Vacasa shareholder, click here to learn more about your legal rights and options.
Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders. We would handle the action on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.
Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
One World Trade Center
85th Floor
New York, NY 10007
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com
